Z-0489-2025 Class II Ongoing
FDA device recall Z-0489-2025 was initiated by Roche Diagnostics Operations, Inc. on Oct 17, 2024 and is designated Class II. Reason for recall: Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias) The recall status is ongoing. Affected quantity: 458 units.
Recall details
- Product Type
- Devices
- Report Date
- Nov 27, 2024
- Initiation Date
- Oct 17, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 458 units
Product description
cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine
Reason for recall
Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
Distribution pattern
US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,
Code information
UDI/DI 04015630929979, Lot Number 747029, exp. 30-SEPT-2024
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0489-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026